◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
ALNY
ALNY
(ALNY)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
MT Newswires
·
vor 2 Std.
Alnylam Initiates Mid-Stage Study of Mivelsiran in Down Syndrome-Associated Alzheimer's
Business Wire
·
vor 5 Std.
Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease
Insider Monkey
·
vor 20 Std.
Morgan Stanley Raises its Price Target on Alnylam (ALNY)
MT Newswires
·
vor 21 Std.
Alnylam Pharmaceuticals' Q2 Results to Determine 2026 Revenue Outlook, BofA Securities Says
MT Newswires
·
vor 1 Tagen
BofA Securities Cuts Alnylam Pharmaceuticals Price Target to $410 From $460, Maintains Buy Rating
MarketBeat
·
vor 1 Tagen
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
Frag BlackSpecter AI über ALNY
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist ALNY kaufenswert?
ALNY Earnings Analyse
ALNY Bewertung
AI Chat öffnen →